Age-related musculoskeletal diseases are becoming increasingly burdensome in terms of both individual quality of life and medical cost. We intended to establish a large population-based cohort study to determine environmental, lifestyle, and genetic risk factors of musculoskeletal and other age-related diseases, and to clarify the association between vitamin D status and such diseases.
Methods
We targeted 34,802 residents aged 40–74 years living in areas of northern Niigata Prefecture, including Sekikawa Village, Awashimaura Village, and Murakami City (Murakami region). The baseline questionnaire survey, conducted between 2011 and 2013, queried respondents on their lifestyle and environmental factors (predictors), and self-reported outcomes. Plasma 25-hydroxyvitamin D (25[OH]D) concentration, an indicator of vitamin D status, was determined with the Liaison® 25OH Vitamin D Total Assay. The primary outcome of this study was osteoporotic fracture; other outcomes included age-related diseases including knee osteoarthritis, perception of chronic pain, dementia, and long-term care insurance use. Mean ages of men and women were 59.2 (SD = 9.3, N = 6907) and 59.0 (SD = 9.3, N = 7457) years, respectively. From the blood samples provided by 3710 men and 4787 women, mean 25(OH)D concentrations were 56.5 (SD = 18.4) nmol/L (22.6 ng/mL) and 45.4 (SD = 16.5) nmol/L (18.2 ng/mL), respectively.
Discussion
Follow-up surveys are planned every 5 years for 15 years, and incident cases of our targeted diseases will be followed at hospitals and clinics in and nearby the cohort area. We anticipate that we will be able to clarify the association between vitamin D status and multiple disease outcomes in a Japanese population.
Norfolk cohort of the European Prospective Investigation into Cancer
EPIDOS
EPIDemiologie de l’OStéoporose
HbA1c
Glycated haemoglobin
HDL
High-density lipoprotein
HR
Hazard ratio
JPHC Study
Japan Public Health Centre-based Prospective Study
LDL
Low-density lipoprotein
OR
Odds ratio
OSTPRE
Osteoporosis Risk Factor and Prevention
PERF
Prospective Epidemiological Risk Factors
SD
Standard deviation
SOF
Study of Osteoporotic Fractures
γ-GTP
Gamma-glutamyltransferase
1 Background
The average life expectancy in Japan is one of the highest in the world. This is attributed in part to successful prevention and treatment of fatal diseases, such as cancer, cardiovascular disease, and cerebrovascular disease. Consequently, ageing is accelerating. In 2016, 27.3% of the population comprised elderly persons over 65 years, and that in 2055 is projected to be as high as 38.0% [1]. In such an ageing society, common age-related diseases, such as musculoskeletal diseases, become highly burdensome in terms of both individual quality of life and medical cost. For example, osteoporotic fracture and knee osteoarthritis impair physical function, leading to decreased levels of activities of daily living (ADL), and eventually to higher numbers of elderly individuals with physical disabilities requiring care. The National Livelihood Survey of the Ministry of Health, Labour and Welfare in Japan [1] reported that fractures and knee osteoarthritis account for 10.2 and 10.9%, respectively, of all cases of disability requiring care, and the sum of these (21.1%) is comparable to the percentage of individuals with cerebrovascular diseases (21.5%) and dementia (15.3%). Furthermore, musculoskeletal disorders are a main cause of chronic pain, which is also becoming a major public health concern [2].
The economic burden on medical insurance companies from musculoskeletal and other age-related diseases causing disability has been enormous. For example, the annual cost of treatment and after-care for hip and vertebral fractures in Japan has been estimated as 750 and 150 billion yen (nearly equivalent to 7.5 and 1.5 billion dollars), respectively [3]. Rapid increases in the economic burden on long-term care insurances are also problematic in Japan. The cost of the long-term care insurance in 2000 was 3.6 trillion yen, but had over doubled this amount, to 9.8 trillion yen in 2015 [1]. Accordingly, prevention of age-related musculoskeletal diseases is a top priority at present and in the near future.
Anzeige
With regard to age-related diseases, vitamin D has received increasingly more attention, as its insufficiency is considered a potential risk factor for age-related bone diseases [4] and other age-related chronic diseases, such as some cancers, vascular diseases, diabetes, and dementia [5, 6].Vitamin D status is also of great interest because vitamin D insufficiency is widespread worldwide [7]. Although a number of cohort studies on vitamin D status and chronic diseases have been conducted in European and North American countries, large cohort studies that target East Asian populations are lacking [8].
Over the last several years, we have conducted medium-scale epidemiologic studies on vitamin D status, osteoporosis, and osteoporotic fractures in Japanese populations and reported that higher vitamin D concentrations are associated with higher bone mass and a lower incidence of osteoporotic fractures [8, 9]. Japanese people are an interesting population in terms of vitamin D nutrition because they frequently eat fish, a major source of vitamin D, and consume much more fish than populations in Europe and North America [10]. This implies that some lifestyles, including dietary habits, could impact vitamin D status and bone health. Comprehensive approaches, including genetic information, should be used to determine risk factors for osteoporotic fractures.
Against this backdrop, the present study aimed to establish a large population-based cohort study to determine (1) environmental, lifestyle, and genetic risk factors of osteoporotic fractures, and their interactions; (2) factors related to other age-related diseases, including knee osteoarthritis, chronic pain, dementia, disability, and some cancers; and (3) the impact of vitamin D status on the incidence of these diseases or disorders.
2 Methods/design
2.1 Participants
The Murakami Cohort Study is a population-based study of age-related musculoskeletal diseases that targeted individuals aged between 40 and 74 years living in areas of northern Niigata Prefecture under the jurisdiction of the Murakami Public Health Centre (Murakami region). These areas include Sekikawa Village (3065 residents on April 1, 2011), Awashimaura Village (178 residents on January 1, 2011), and Murakami City (31,559 residents on January 1, 2012) (Fig. 1). All 34,802 residents in the Murakami region aged between 40 and 74 years were invited to participate in the study. Of these, 14,364 (41.3%) participated in the cohort study, and 8497 of the 14,364 participants provided blood samples. Informed consent was obtained from all participants. The protocol of this study was approved by the Ethics Committee of Niigata University School of Medicine (No. 1324 for study design and 452 and 481 for genetic analysis).
Fig. 1
Location of Murakami City, Sekikawa Village, and Awashimaura Village in Niigata Prefecture, Japan
×
Anzeige
2.2 Baseline study
In the baseline survey, a self-administered questionnaire was distributed through a community-based communication network to Sekikawa residents and Awashimaura residents in early 2011 and to Murakami City residents in late 2011 and early 2012. Questionnaires were completed by those who agreed to participate in the study and collected through the network. A supplemental mail survey was used for communities where such a network is not available. At the time of the baseline survey, participants were asked to provide blood samples for future biochemical and genetic analyses. Blood sampling was performed only among those who provided consent between 2011 and early 2013 at one of the following settings: annual health check examinations provided by the local government, workplace health check examinations, local hospitals, clinics, and health care facilities of internal medicine, and an additional setting provided by our team. Blood samples were collected directly by our team, except at local hospitals, clinics, and health care facilities, where quality control of samples was ensured by respective clinical laboratories and samples were collected through BML, Inc. (Tokyo, Japan). Additional participants were recruited from annual health check examinations and workplace health check examinations between 2012 and 2013. In a subsample, clinical examination data of participants were collected from annual health check examinations provided by the local government or workplace health check examinations.
2.3 Follow-up plans
Follow-up questionnaire surveys are planned every 5 years for 15 years, with the aim to reevaluate exposures, such as lifestyles, and obtain self-reported outcomes, such as chronic pain.
Most outcome measures, e.g., incident cases of target diseases, are thoroughly be followed every year for 20 years at relevant hospitals and clinics in the Murakami region and secondary or tertiary medical centres around the Murakami region (Niigata Prefectural Shibata Hospital and Tsuruoka Municipal Shonai Hospital). Incident cases of osteoporotic fractures and osteoarthritis are followed at hospitals and clinics involved in orthopaedics, including Murakami General Hospital, Sakamachi Hospital, Sanpoku Tokushukai Hospital, Sasaki Orthopaedic Clinic, Takahashi Orthopaedic Clinic, and Arakawa Chuo Clinic in Murakami City, Nakajo Chuo Hospital in Tainai City, Niigata Prefectural Shibata Hospital in Shibata City, and Tsuruoka Municipal Shonai Hospital in Tsuruoka City. Certification of long-term care insurance is investigated by the local governments. Dementia cases are tracked in the abovementioned hospitals and three additional medical institutions involved in neurology, including Murakami Hamanasu Hospital, Sano Clinic in Murakami City and Kurokawa Hospital in Tainai City. Information regarding disabilities is obtained from the long-term care insurance registry of local governments. Incident cases of cancers are followed with the cancer registry of Niigata Prefecture. Mortality and moving information are obtained from residency registration and death registration according to the Basic Residential Registry Law and Family Registry Law to calculate person-years of observation, because cases of death and moving out are censored.
2.4 Self-administered questionnaire
The questionnaire was designed according to that used in the Japan Public Health Centre-based Prospective Study [11] (JPHC Study) and JPHC Study for the Next Generation (JPHC-NEXT Study) [12]. The questionnaire collected sociodemographic characteristics, family information, medical histories, body size, lifestyle, dietary intake [13]; physical and mental health (including chronic pain [14, 15]); and reproductive history (for women only). Details are provided in Table 1. Data management procedures were carried out based on the JPHC Studies [11, 12].
Table 1
Items of the self-administered questionnaire at baseline
Measures
Sociodemographics
Age
Sex
Marital status
Occupation
Education
Household income
Family information
Family structure
Family disease histories
Medical history
Fractures
Knee osteoarthritis
Cancer
Cardiovascular disease
Cerebrovascular disease
Other chronic diseases
Histories of medication use
Body size
Current weight
Weight in the previous year
Weight at 20 years of age
Birth weight
Height
Waist circumference
Lifestyle
Smoking status
Alcohol consumption
Tea and coffee consumption
Physical activity
Time spent outdoors
Dietary habits
Dietary and nutritional intake (intakes of energy, 53 nutrients, and 29 food groups) using a validated food frequency questionnaire [13]
Sleep
Physical and mental health
Activities of daily living
Chronic pain*
General health status
Quality of life
Reproductive history (for women only)
Menstrual history
Pregnancy and birth histories
Breastfeeding history
History of hormone use
History of toxaemia in pregnancy
*Pain was evaluated using the Short Form 36 verbal rating scale [14, 15]
We verified self-reported height and body weight using anthropometric data from health check examinations. Pearson’s and Spearman’s correlation coefficients between self-reported and measured data were 0.9160 and 0.9743 for male height, 0.9249 and 0.9753 for female height, 0.9490 and 0.9720 for male body weight, and 0.8737 and 0.9729 for female body weight, respectively (male N = 1752, female N = 2259, P < 0.0001 for all coefficients).
2.5 Baseline blood collection and examination
Fasting or non-fasting blood specimens were drawn with EDTA-2Na-containing tubes (7 mL) during the day and immediately stored at 4 °C in all settings. Their plasma and buffy coat were obtained by centrifugation at 1613 × g for 10 min in the laboratory of Niigata University Division of Preventive Medicine and stored at − 80 °C until biochemical analysis. Plasma 25-hydroxyvitamin D (25[OH]D) concentrations were determined with the Liaison® 25OH Vitamin D Total Assay (DiaSorin Inc.; Stillwater, MN, USA). Intra- and inter-assay coefficient of variation (CV) values were 3.2–8.1% and 6.9–12.7%, respectively.
For laboratory analyses at health check examinations, routine blood tests were analysed at two certified clinical laboratories of the Shibata Comprehensive Health Care Service Centre (Niigata, Japan) and BML, Inc. (Tokyo, Japan). Routine standardisation and calibration tests were conducted at these facilities.
2.6 Main outcome measures
The primary outcome of this study was osteoporotic fracture. The secondary outcomes were age-related diseases, including knee osteoarthritis, perception of chronic pain, dementia, disability (long-term care insurance use), and some cancers. Osteoporotic fracture was defined as a fracture caused by minimal trauma due to reduced bone strength [16] and typically included vertebral compression fracture, hip fracture, and other long-bone fractures. Knee osteoarthritis was diagnosed with the Kellgren-Lawrence grade scale. Chronic pain is defined as pain lasting more than 6 months [17], and its presence was determined with the self-administered questionnaire. Other outcomes included some cancers potentially involved in vitamin D status, such as colorectal and breast cancers.
Anzeige
2.7 Future statistical plans
Cox’s proportional hazards model will be used to calculate hazard ratios (HRs) of most outcome variables in relation to levels of exposure. Regarding self-reported outcomes, including chronic pain, a logistic regression model will be used to calculate odds ratios (ORs). In the multivariate model, HRs and ORs will be adjusted for potential confounders.
2.8 Sample size
Validity of the sample size of this study should be discussed. We predict that we will observe 193,914 person-years (14,364 participants × 90% × 15 years) in the 15-year follow-up. Regarding hip fracture, one of our major outcomes, 211 new cases will be observed during the 15-year follow-up (with a 90% follow-up rate), according to data from Fujiwara et al.’s 14-year cohort study on hip fracture [18]. With these constraints, we could detect relative risks of 1.7 for the highest quartile to the lowest quartile of a predictor, given an average estimated incidence of 0.016 (211/[14,364 × 90%]), 80% statistical power, and α = 0.05. When limited to participants who provide blood samples (N = 8497), we could detect relative risks of 2.0 for the highest quartile of plasma 25(OH)D, applying the same assumption. Because the incidences of the other outcomes in this study are higher than that of hip fracture, we could determine their risk factors with more statistical power.
2.9 Participant characteristics
Mean ages of men and women were 59.2 (SD = 9.3, N = 6907) and 59.0 years (SD = 9.3, N = 7457), respectively. Demographic, physical, and lifestyle characteristics among the 14,364 participants are displayed by sex and blood sample status in Table 2. Past or current histories of self-reported musculoskeletal events or disorders are shown in Table 3. In women, prevalence of all histories increased significantly with age. In men, prevalence of history of spinal fracture, knee osteoarthritis, and chronic pain increased significantly with age, but prevalence of histories of forearm and hip fractures and fall did not. The mean plasma 25(OH)D concentration in all participants who provided blood samples was 50.3 nmol/L (SD = 18.2, N = 8497). Mean plasma 25(OH)D concentrations by sex, age group, and season of blood collection are shown in Table 4. Health check examination data by sex (N = 4014) are shown in Table 5.
Table 2
Characteristics (numbers) of 14,364 participants by sex and blood sample status
Sex
Blood samples
Characteristics
Men (N = 6907)
Women (N = 7457)
Present (N = 8497)
Absent (N = 5867)
Age group (years)
P = 0.1804
P < 0.0001
≤ 49
1277 (18.5%)
1429 (19.2%)
1483 (17.5%)
1213 (20.7%)
50–59
1938 (28.1%)
2161 (29.0%)
2333 (27.5%)
1746 (29.8%)
60–69
2596 (37.6%)
2759 (37.0%)
3399 (40.0%)
1952 (33.3%)
≥ 70
1096 (15.9%)
1108 (14.9%)
1282 (15.1%)
956 (16.3%)
Education level
P < 0.0001
P < 0.0001
Junior high school
1889 (28.2%)
2368 (32.6%)
2330 (28.0%)
1927 (34.2%)
High school
3597 (53.6%)
3360 (46.3%)
4258 (51.1%)
2699 (47.9%)
Junior college
614 (9.2%)
1338 (18.4%)
1263 (15.2%)
689 (12.2%)
University or higher
607 (9.0%)
194 (2.7%)
482 (5.8%)
319 (5.7%)
Household income (yen)
P < 0.0001
P = 0.0282
0–2,990,000
2199 (33.6%)
2687 (41.2%)
1967 (38.3%)
2919 (36.8%)
3,000,000–5,990,000
2786 (42.6%)
2409 (36.9%)
1956 (38.1%)
3239 (40.8%)
6,000,000–8,990,000
1056 (16.1%)
944 (14.5%)
795 (15.5%)
1205 (15.2%)
9,000,000–11,990,000
305 (4.7%)
295 (4.5%)
253 (4.9%)
347 (4.4%)
≥12,000,000
190 (2.9%)
195 (3.0%)
160 (3.1%)
225 (2.8%)
Activities of daily living
P = 0.0455
P < 0.0001
No disability
6369 (93.5%)
6798 (92.3%)
7968 (94.1%)
5199 (91.1%)
Some disability, but able to go out alone
399 (5.9%)
520 (7.1%)
481 (5.7%)
438 (7.7%)
Living by oneself indoors, but need help outdoors
25 (0.4%)
26 (0.4%)
11 (0.1%)
40 (0.7%)
Need help indoors
4 (0.1%)
2 (0.0%)
0 (0.0%)
6 (0.1%)
Bedridden
14 (0.2%)
19 (0.3%)
6 (0.1%)
27 (0.5%)
Body mass index
P < 0.0001
P < 0.0001
< 18.5
206 (3.0%)
492 (6.6%)
400 (4.7%)
298 (5.2%)
18.5–24.9
4614 (67.2%)
5313 (71.7%)
6040 (71.2%)
3887 (67.2%)
25.0–29.9
1810 (26.4%)
1341 (18.1%)
1791 (21.1%)
1360 (23.5%)
≥ 30.0
233 (3.4%)
261 (3.5%)
256 (3.0%)
238 (4.1%)
Smoking (cigarettes/day)
P < 0.0001
P < 0.0001
Non-smoker
1244 (18.1%)
6335 (85.5%)
4868 (57.4%)
2711 (46.8%)
Past smoker
3338 (48.6%)
548 (7.4%)
2312 (27.3%)
1574 (27.2%)
1–19
824 (12.0%)
394 (5.3%)
582 (6.9%)
636 (11.0%)
≥ 20
1462 (21.3%)
130 (1.8%)
721 (8.5%)
871 (15.0%)
Alcohol consumption (grams of ethanol/week)
P < 0.0001
P < 0.0001
None or rarely
1333 (19.4%)
4899 (66.0%)
3715 (43.8%)
2517 (43.3%)
1–149
1730 (25.2%)
2009 (27.1%)
2419 (28.5%)
1320 (22.7%)
150–299
1335 (19.4%)
271 (3.7%)
935 (11.0%)
671 (11.6%)
300–449
1213 (17.6%)
149 (2.0%)
753 (8.9%)
609 (10.5%)
≥ 450
1265 (18.4%)
91 (1.2%)
666 (7.9%)
690 (11.9%)
Sex
P < 0.0001
Men
–
–
3710 (43.7%)
3197 (54.5%)
Women
–
–
4787 (56.3%)
2670 (45.5%)
P values were calculated by the χ2 test between men and women and between those with and without blood samples. Missing values are generated except for “age group” and “sex”
Table 3
Past or current histories of self-reported musculoskeletal events or disorders in 14,364 participants by sex and age groups
Men
Women
Musculoskeletal disorders
≤ 49 years old
50–59 years old
60–69 years old
≥ 70 years old
P for trend
≤ 49 years old
50–59 years old
60–69 years old
≥ 70 years old
P for trend
Past history of fracture*of
Lumbar region
3/1272
4/1933
12/2593
12/1093
0.0018
1/1423
4/2154
12/2752
9/1102
0.0011
(0.2%)
(0.2%)
(0.5%)
(1.1%)
(0.1%)
(0.2%)
(0.4%)
(0.8%)
Forearm
37/1272
71/1933
76/2593
22/1093
0.1107
20/1423
35/2154
89/2752
51/1102
< 0.0001
(2.9%)
(3.7%)
(2.9%)
(2.0%)
(1.4%)
(1.6%)
(3.2%)
(4.6%)
Hip
6/1272
6/1933
5/2593
4/1093
0.4062
0/1423
1/2154
5/2752
3/1102
0.0272
(0.5%)
(0.3%)
(0.2%)
(0.4%)
(0.0%)
(0.0%)
(0.2%)
(0.3%)
Past history of fall†
272/1234
368/1875
496/2535
248/1064
0.6960
212/1395
383/2114
497/2700
244/1072
< 0.0001
(22.0%)
(19.6%)
(19.6%)
(23.3%)
(15.2%)
(18.1%)
(18.4%)
(22.8%)
Current knee osteoarthritis
13/1265
52/1913
204/2576
131/1078
< 0.0001
31/1417
158/2145
397/2735
273/1091
< 0.0001
(1.0%)
(2.7%)
(7.9%)
(12.2%)
(2.2%)
(7.4%)
(14.5%)
(25.0%)
Current chronic pain‡
389/1265
631/1913
988/2576
436/1078
< 0.0001
442/1417
782/2145
1107/2735
527/1091
< 0.0001
(30.8%)
(33.0%)
(38.4%)
(40.5%)
(31.2%)
(36.5%)
(40.5%)
(48.3%)
*Subjects were asked to report fractures that were not caused by high energy trauma, such as a motor vehicle accident, fall from a higher level than a standing height, or occupational accident
†Subjects were asked to report falls from a standing height or less
‡Subjects were asked to report pain lasting for more than 6 months in any part of the body
Table 4
Mean plasma 25-hydroxyvitamin D concentrations and standard deviations (SDs) by sex, age group, and season in 8497 participants providing blood samples
25-hydroxyvitamin D (nmol/L)
N
Mean
SD
P value*
Sex
Men
3710
56.5
18.4
< 0.0001
Women
4787
45.4
16.5
Age group (years)
< 49
1489
42.9
17.6
Reference
50–59
2345
47.7
17.7
< 0.0001
60–69
3400
53.7
17.9
< 0.0001
≥ 70
1263
54.5
17.0
< 0.0001
Season of blood collection
Spring (Mar–May)
1905
44.9
17.4
Reference
Summer (Jun–Aug)
3890
50.8
17.6
< 0.0001
Autumn (Sep–Nov)
2375
53.9
18.6
< 0.0001
Winter (Dec–Feb)
327
48.8
19.5
0.0047
Multiply the values by 0.4 to convert nmol/L to ng/mL for 25-hydroxyvitamin D
*T test was used to analyse sex, and Dunnett’s test was used for the other variables
A number of population-based cohort studies to determine risk factors for osteoporotic fracture have been conducted in European and North American countries [19]. Among them, large-scale studies (n > 5000) include the CaMos (N = 5143, ≥ 25 years old) [20], EPIC-Norfolk (N = 14,824, 42–82 years old) [21], EPIDOS (N = 7598, ≥ 75 years old) [22], OSTPRE (N = 12,191, 47–56 years old) [23], PERF (N = 5564, 45–70 years old) [24], Rotterdam (N = 14,926, ≥ 45 years old) [25], and SOF (N = 9516, ≥ 65 years old) [26] studies. In Japan, the Fujiwara-kyo Study (N = 4427, ≥ 65 years old) [27] is an ongoing cohort study on osteoporotic fractures. The Murakami Cohort Study is considered one of the largest studies on osteoporotic fractures, comparable to previous studies.
Anzeige
We have established a population-based cohort study on musculoskeletal and other age-related diseases with a sufficient sample size and plan to follow our population for 15 years. We anticipate that we will be able to clarify the association between vitamin D status and multiple disease outcomes in a Japanese population. The present study is one of the largest cohort studies to clarify the effects of vitamin D in an Asian population. One strength of this cohort study is related to the geographical features of the Murakami region. As it is surrounded by mountains and sea, this region has high rates of self-sufficient medical care, namely, its self-sufficient rates for the three fatal diseases in Murakami City have been reported to be 68.5% for cancer, 91.1% for cerebrovascular disease, 80.8% for cardiovascular disease, and 81.4% for a total of the three diseases [28]. Self-sufficiency for medical care of unfatal diseases, such as musculoskeletal diseases, is considered to be equal to or higher than that for fatal diseases. Therefore, we should be able to identify most cases of our targeted diseases.
This study has some potential limitations. First, although a large number of people participated, the participation rate was not very high (41.3%). In addition, no information on medication use was collected from participants. Therefore, our results may not accurately reflect the entire population of the study area. Second, generalisation of our results should be made with caution. The Murakami region includes medium- and small-sized local governments. Therefore, while our results can be generalised to regions with similar-sized populations, they may not apply to regions with larger local governments or metropolitan governments (e.g., Tokyo). Moreover, lifestyles differ between the Murakami region and metropolitan regions. For instance, many elderly living in medium or small communities in Japan retain old, traditional lifestyles, which also include particular dietary habits. Finally, in some fracture studies, bone mineral density (BMD) is measured to evaluate individual bone mass, because low BMD, i.e., osteopenia or osteoporosis, is established as a clinical risk factor for osteoporotic fracture. For this reason, the present study does not contribute to the prevention of osteoporosis or to the secondary prevention of osteoporotic fracture.
Acknowledgements
We are indebted to Kyowa Medex Co., Ltd. and DiaSorin Inc. for the plasma 25(OH)D assay. We also thank the following institutions for their help in blood collection: Murakami Public Health Center (Niigata Prefecture), Murakami City Government, Sekikawa Village Government, Awashimaura Village Government, the Medical Association of Murakami City and Iwafune District, Murakami General Hospital, Niigata Prefectural Sakamachi Hospital, Sampoku Tokushukai Hospital, Murakami Memorial Hospital, Senami Hospital, Sakanamachi Hospital, Aoki Clinic, Arakawa Chuo Clinic, Anzai Clinic, Hatori Clinic, Homma Clinic, Iga Clinic, Otabe Clinic, Sakura Clinic of Internal Medicine, Sano Clinic, Sato Clinic, Sato Clinic of Internal Medicine, Sato Clinic of Internal Medicine and Pediatrics, Sawada Clinic, Sega Clinic, Sekikawa Medical Office, Suzuki Clinic (Murakami City), Suzuki Clinic (Tainai City), Shibata Comprehensive Health Care Service Centre, Kenko-Igaku-Yobo-Kyokai, Niigata Association of Occupational Health, Niigata Health Care Association, BML, Inc., and Kotobiken Medical Laboratories, Inc.
Funding
This work was supported in part by JSPS KAKENHI Grants (Nos. JP23249035, JP40339958, and JP16K09078) and the National Cancer Center Research and Development Fund (23-A31[toku] and 26-A-2). The funders have no role in the study design, including collection, management, analysis, and interpretation of data; writing of the report; or the decision to submit the report for publication.
Anzeige
Availability of data and materials
The datasets generated and/or analysed during the current study are not publicly available because all study participants did not consent to have their data provided to anyone outside of the research group. However, a minimal dataset may be available upon ethical approval by the Ethics Committee of Niigata University.
Informed consent was obtained from all participants. The protocol of this study was approved by the Ethics Committee of Niigata University School of Medicine (No. 1324 for study design and 452 and 481 for genetic analysis).
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
